Back
Janux Therapeutics, Inc. Stock Predictions
This Tech Company Grew 32,481%...
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Sell
30
JANX
Janux Therapeutics, Inc.
Last Price:
$13.59
Seasonality Move:
-11.9%
7 Day Trial
ALL ACCESS PASS
$
7
Janux Therapeutics, Inc. Stock Forecast
-
Over the next 52 weeks, Janux Therapeutics, Inc. has on average historically risen by 18.3% based on the past 4 years of stock performance.
-
Janux Therapeutics, Inc. has risen higher in 1 of those 4 years over the subsequent 52-week period, corresponding to a historical accuracy of 25%
-
Is Janux Therapeutics, Inc. Stock Undervalued?The current Janux Therapeutics, Inc. [JANX] share price is $14.08. The Score for JANX is 30, which is 40% below its historic median score of 50, and infers higher risk than normal.
-
JANX is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
Will Janux Therapeutics, Inc. Stock Go Up Next Year?
-
Over the next 52 weeks, Janux Therapeutics, Inc. has on average historically risen by 18.3% based on the past 4 years of stock performance.
Janux Therapeutics, Inc. Stock Rating
Sell
30
Janux Therapeutics, Inc. (JANX)
is a Sell
Is Janux Therapeutics, Inc. overpriced?
-
Janux Therapeutics, Inc. has risen higher in 1 of those 4 years over the subsequent 52-week period, corresponding to a historical accuracy of 25%
Janux Therapeutics, Inc. Stock Price History
Stock Information
Stock Info
Exchange:
NASDAQ
Country:
United States
Industry:
Biotechnology
Sector:
Health Care
Type:
stock
Website:
januxrx.com
52-Week Data
52-Week High:
35.34
52-Week Low:
12.12
Prediction Charts
Market Cap:
856.5M
Price in USD:
14.08
Volume:
565K
Beta:
2.93
Technical Analysis
SMA50:
13.71
SMA100:
18.76
SMA200:
21.58
52-Wk Change:
-51.86%
Stock Predictions
-
Is Janux Therapeutics, Inc. stock public?Yes, Janux Therapeutics, Inc. is a publicly traded company.
-
What is the Janux Therapeutics, Inc. stock quote today?The Janux Therapeutics, Inc. stock price is 14.08 USD today.
-
How to buy Janux Therapeutics, Inc. stock online?You can buy Janux Therapeutics, Inc. shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
14-Day Historical Data
| Date | Opening | Closing | Minimum | Maximum |
|---|---|---|---|---|
| Feb-20 | 13.29 | 13.08 | 13.39 | 13.02 |
| Feb-23 | 13.03 | 13.37 | 13.41 | 12.96 |
| Feb-24 | 13.37 | 13.65 | 13.77 | 13.37 |
| Feb-25 | 13.54 | 13.70 | 14.00 | 13.39 |
| Feb-26 | 13.70 | 13.80 | 13.86 | 13.47 |
| Feb-27 | 13.58 | 13.61 | 13.87 | 13.40 |
| Mar-2 | 13.30 | 13.42 | 13.73 | 13.17 |
| Mar-3 | 13.05 | 13.44 | 13.63 | 12.97 |
| Mar-4 | 13.52 | 14.35 | 14.46 | 13.34 |
| Mar-5 | 14.02 | 13.97 | 14.12 | 13.66 |
| Mar-6 | 13.67 | 13.84 | 13.96 | 13.50 |
| Mar-9 | 13.65 | 13.98 | 14.30 | 13.58 |
| Mar-10 | 14.02 | 14.07 | 14.14 | 13.84 |
| Mar-11 | 14.08 | 14.08 | 14.14 | 13.71 |
Janux Therapeutics, Inc. Earnings
Janux Therapeutics, Inc. Earnings Report: Per Share Janux Therapeutics, Inc. Earnings Q1 Q2 Q3 and Q4 last year and next year.
Janux Therapeutics, Inc. Forecast Revenue Growth
Janux Therapeutics, Inc. Stock Analysis: Historical quarterly revenues per share for Janux Therapeutics, Inc. and historical quarterly revenue growth:
-
Analysts estimate an earnings decrease this quarter of $0.07 per share, a decrease next quarter of $0.05 per share, a decrease this year of $0.62 per share, and a decrease next year of $0.90 per share.
* Janux Therapeutics, Inc. stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.